phase readout
saveNCT07366086: Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Amgen. Phase: PHASE3. Conditions: Osteogenesis Imperfecta
view source ↗
comments(0)
5-min edit window · permanent after that